![Joseph Horvat](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joseph Horvat
Präsident bei
Oncopeptides, Inc.
Profil
Joseph R.
Horvat is currently President at Oncopeptides, Inc. Formerly, Mr. Horvat was General Manager at MorphoSys US, Inc. and Chief Commercial Officer at PharmaEssentia Corp.
Mr. Horvat completed undergraduate studies at the University of Alberta.
Aktive Positionen von Joseph Horvat
| Unternehmen | Position | Beginn |
|---|---|---|
Oncopeptides, Inc.
 Oncopeptides, Inc. Medical/Nursing ServicesHealth Services Develops therapies for hematological diseases | Präsident | - |
Ehemalige bekannte Positionen von Joseph Horvat
| Unternehmen | Position | Ende |
|---|---|---|
MorphoSys US, Inc.
 MorphoSys US, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Novartis AG, MorphoSys US, Inc. is a company based in Boston, MA. | Corporate Officer/Principal | - |
| PHARMAESSENTIA CORPORATION | Corporate Officer/Principal | - |
Ausbildung von Joseph Horvat
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
2
Beziehungen ersten Grades
4
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
University of Alberta
 University of Alberta Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PharmaEssentia Corp.
 PharmaEssentia Corp. Pharmaceuticals: MajorHealth Technology Manufactures and sells therapeutic products for the treatment of hematologic diseases | Health Technology |
MorphoSys US, Inc.
MorphoSys US, Inc. Miscellaneous Commercial ServicesCommercial Services Part of Novartis AG, MorphoSys US, Inc. is a company based in Boston, MA. | Commercial Services |
Oncopeptides, Inc.
Oncopeptides, Inc. Medical/Nursing ServicesHealth Services Develops therapies for hematological diseases | Health Services |
